Biomarker Use for Evaluating mTBI: A Game-changing New Technology
Learning Objectives
- Review the latest research, best practices, challenges and developments to advance assessment and care for patients suspected of mTBI
- Demonstrate how biomarker-based testing can provide objective assessment of suspected mTBI and examine and examine the potential to reduce unnecessary head CT, improve patient care and satisfaction, and improve operational efficiency
- Examine how physiologic, social, and environmental factors impact the clinical manifestations in mTBI/concussion
- Illustrate a multidisciplinary approach to the neurobehavioral presentations of mTBI patients post ED-discharge
Speaker
CHRIS DAVLANTES, MD, FACEP
Emergency Medicine Physician,
Senior Director, Global Medical Affairs, Abbott
Dr. Davlantes is the Sr. Director of Global Medical Affairs at Abbott Point of Care. Board-certified by the American Board of Emergency Medicine, he has practiced Emergency Medicine for over 25 years and is a Fellow of the American College of Emergency Physicians. Dr. Davlantes has held the position of Assistant Professor in the Department of Emergency Medicine at the University of Kansas Hospital for the past 9 years, and he is still practicing Emergency Medicine part-time at Northwell Health system’s Lenox Health Greenwich Village, a free-standing ED located in Manhattan, New York City, where he and his wife relocated during the beginning of the COVID-19 pandemic. Dr. Davlantes has been working as a global Medical Affairs leader in the medical device industry since 2012, where his focus and passion has been to bridge innovative technologies with clinical unmet needs in order to improve patient outcomes around the globe.